Doxorubicin (Xenetic Biosciences/Pharmsynthez)

N/A

Report date: 2026/01/26 13:50:14

Base Information

Drug NameDoxorubicin (Xenetic Biosciences/Pharmsynthez)
Drug Alias NameDoxorubicin (Lipoxen/Pharmsynthez)Doxorubicin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitorsVirus DNA polymerase inhibitors
TargetsVirus DNA polymeraseDNATopoisomerase II
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenetic Biosciences (Uk) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenetic Biosciences (Uk) LtdPharmsynthez
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A